SCHEMBL936068

SCHEMBL936068

CCOC(=O)c1cc(NS(=O)(=O)c2ccc(OCc3ccccc3)cc2)cc(C(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.65
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
AR P10275 7/20 0.59
POLB P06746 1/20 0.54
PKM P14618 1/20 0.54
GPR55 Q9Y2T6 1/20 0.52
LMNA P02545 3/20 0.51
KDM4E B2RXH2 2/20 0.51
NPC1 O15118 1/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPT P10636 1/20 0.50
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
PGR P06401 1/20 0.48
NHERF1 O14745 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL936067 0.87 AR (0.63) TDP1MEN1KMT2AARPOLB
SCHEMBL4195770 0.81 MEN1 (0.70) MEN1KMT2APKMLMNASMN1; SMN2
SCHEMBL6840895 0.81 MRGPRX4 (0.57) TDP1MEN1KMT2APOLBPKM
SCHEMBL935376 0.81 KMT2A (0.50) MEN1KMT2APOLBPKMLMNA
SCHEMBL665516 0.80 AR (0.78) TDP1MEN1KMT2AARPOLB
SCHEMBL13265664 0.78 TDP1 (0.69) TDP1LMNAKDM4ENPC1HTT
SCHEMBL2894616 0.77 NHERF1 (0.79) TDP1MEN1KMT2ALMNAKDM4E
SCHEMBL935592 0.76 MEN1 (0.50) TDP1MEN1KMT2APKMGPR55
SCHEMBL31634228 0.76 AR (0.74) TDP1MEN1KMT2AARPOLB
SCHEMBL340618 0.76 MAOB (0.67) TDP1KMT2ALMNAGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470860-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2013-06-25 US disclosed
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX, LIMITED (GB) 2011-01-27 US disclosed
US-7763642-B2 Phenyl-sulfamates as aromatase inhibitors STERIX LTD. (GB) 2010-07-27 US disclosed
EP-1753732-B1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LTD (GB) 2009-12-02 EP disclosed
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors STERIX LIMITED (GB) 2007-05-24 US disclosed
EP-1753732-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS Sterix Limited (GB) 2007-02-21 EP disclosed
WO-2005118560-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS STERIX LIMITED (GB) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070117855-A1 Phenyl-sulfamates as aromatase inhibitors CYP19A1, CYP17A1, CYP21A2 TDP1 2742/4885MEN1 3186/4885KMT2A 907/4885
US-20110021586-A1 PHENYL-SULFAMATES AS AROMATASE INHIBITORS CYP19A1, CYP17A1, CYP21A2 TDP1 2742/4885MEN1 3186/4885KMT2A 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.